Here’s whether Eli Lilly & Co. (LLY) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.93% over 10 days); RSI 49 — healthy momentum range; strong 1-year return of +48.5%; 3-month momentum positive (+35.3%). Currently 4.3% off its 52-week high. Score: +7/7.
LLY is in a confirmed uptrend, trading above both its 50-day ($1,129.42) and 200-day ($1,016.12) moving averages. An RSI of 49.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +48.5% compares to +16.5% for SPY (beat the market by 32.0%).
$10,000 invested 1 year ago→ $14,850 today
vs. S&P 500 (SPY) — same period beat market by 32.0%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($1,016.12)
✓Above 50-day MA ($1,129.42)
✓RSI(14) neutral zone (30–70) — currently 49.2
✓Positive return (+48.5%)
✓Within 10% of period high (−4.3%)
Period Range $1,196.03
$623.78$1,249.45
RSI (14) 49.2
0 · OversoldOverbought · 100
Key Metrics
Price$1,196.03
Period Return+48.5%
Period High$1,249.45
Period Low$623.78
Drawdown−4.3%
MA-50$1,129.42
MA-200$1,016.12
RSI (14)49.2
Avg Volume (30d)2.9M
vs. SPYbeat by 32.0%
Return Rank#221 of 999
Trend Signals
Price is above the 200-day moving average ($1,016.12)
Price is above the 50-day moving average ($1,129.42)